# Xeris Biopharma Tightens FY23 Revenue Guidance From $145M-$165M To $155M-$165M Versus Consensus Of $158.2M
**Penny Stocks News**

**2023-10-16 11:10**

**https://www.ainvest.com/news/xeris-biopharma-tightens-fy23-revenue-guidance-from-145m-165m-to-155m-165m-versus-consensus-of-158-2m-23101000249b13b7e4cae3ea/**

Xeris Biopharma Tightens FY23 Revenue Guidance From $145M-$165M To $155M-$165M Versus Consensus Of $158.2M